Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets
OSAKA, Japan, Feb. 21, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has entered into a research collaboration agreement with InveniAI® LLC (Guilford, Connecticut,… Read More »Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets



